MedTrace Logo

Efficacy of Intravenous Iron Administration in Hemodialysis Patients

NCT00298441 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-05-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether the frequency of intravenous iron administration has an effect on anemia correction and oxidative stress formation in hemodialysis patients.

Conditions

Interventions

DRUG

chondroitin sulfate-iron colloid

Sponsors & Collaborators

  • Kumamoto University

    lead OTHER

Principal Investigators

  • Kenichiro Kitamura, M.D., Ph.D. · Kumamoto University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2006-05-31
Completion
2007-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00298441 on ClinicalTrials.gov